| 产品详情 |
| Edit |   |
|---|
| Product Name | AP-III-a4 |
|---|
| Description | Purity >95%. AP-III-a4 is a small molecule enolase inhibitor (IC50 = 0.576 µM) that inhibited cancer cell metastasis in an in vivo zebrafish cancer cell xenograft model. It also reduced hyperglycemia and hyperlipidemia in C57BL/Ksj-db/db mice, a transgenic model of type 2 diabetes. Another study found that AP-III-a4 did not directly block enolase activity in vitro and suggested the mechanism is indirect. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]-4-[[4-[(cyclohexylmethyl)amino]-6-[[(4-fluorophenyl)methyl]amino]-1,3,5-triazin-2-yl]amino]-benzeneacetamide, ENOblock |
|---|
| Gene, Accession, CAS # | CAS: 1177827-73-4 |
|---|
| Catalog # | LS-H6566 |
|---|
| Price | |
|---|
| Order / More Info | AP-III-a4 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|